GGrantIndex
Sort

64,565 grants matching drug discovery

Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.

$2,798,940
Hugh William Alsop · Kinoxis Therapeutics Pty Ltd · UG3 · FY2019 · DA

Flourescent Probes & Imaging - Networks & Pathways(RMI)

$2,790,795
Alan S Waggoner · Carnegie-Mellon University · U54 · FY2008 · RR

CLINICAL STUDY FOR THE TREATMENT OF HUMAN PRION DISEASES

$2,789,582
Bruce L Miller · University Of California, San Francisco · P01 · FY2007 · AG

Information Resources for Chemical Biology

$2,789,314
Stephen H Bryant · National Library Of Medicine · Z01 · FY2007 · LM

Small Molecule-Mediated Augmentation of Kidney Regeneration

$2,788,277
Neil A Hukriede · University Of Pittsburgh At Pittsburgh · RC4 · FY2010 · DK

Moffitt Cancer Center Support Grant

$2,787,198
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2012 · CA

DNA Replication, Repair, and Mutagenesis In Eukaryotic And Prokaryotic Cells

$2,787,188
Roger Woodgate · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD

Extramural Research Facilities Improvement Program "Dru*

$2,786,306
Harold L. Paz · Pennsylvania State Univ Hershey Med Ctr · C06 · FY2010 · RR

Atrial Fibrillation Post-GWAS: Mechanisms to Treatment

$2,784,815
Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · HL

The Penn Center For Molecular Discovery

$2,783,445
Scott L Diamond · University Of Pennsylvania · U54 · FY2006 · HG

Novel Targeted Therapies for Pulmonary Fibrosis

$2,783,129
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2015 · HL

Molecular mechanism of metabolic stress in the pancreatic beta cells

$2,782,476
Yue Wang · Florida State University · R01 · FY2025 · DK

Moffitt Cancer Center Support Grant

$2,780,246
William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2008 · CA

Moffitt Cancer Center Support Grant

$2,780,246
William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2007 · CA

Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy

$2,779,674
Howard N Hodis · University Of Southern California · R01 · FY2019 · AG

microRNA-based and novel molecular therapeutics in thoracic cancers

$2,778,471
Chuong Hoang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration

$2,776,711
Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2017 · AG

PHARMACOGENOMICS OF ARRHYTHMIA THERAPY

$2,776,081
Vanderbilt University · U01 · FY2003 · HL

Drug Abuse Research Center

$2,775,719
Solomon H Snyder · Johns Hopkins University · P50 · FY2012 · DA

UCLA Center for Biological Radioprotectors

$2,775,205
William H. McBride · University Of California Los Angeles · U19 · FY2007 · AI

Pharmacogenomics of Arrhythmia Therapy

$2,772,165
Dan M Roden · Vanderbilt University · U01 · FY2009 · HL

Discovery of Novel Broad-Spectrum Coronavirus Mpro Inhibitors

$2,770,981
Julien Papillon · University Of Texas Med Br Galveston · U19 · FY2022 · AI

NCI-Frederick Support and Technical Services

$2,769,548
Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2019 · CA

Chimeric anti-Methamphetamine Monoclonal Antibody for Treating Stimulant Toxicity

$2,769,478
R. Barry Holtz · Intervexion Therapeutics, Llc · RC2 · FY2010 · DA

Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy

$2,769,143
Howard N Hodis · University Of Southern California · R01 · FY2022 · AG